Prandin is an oral antidiabetic medication that belongs to the class of meglitinide derivatives. Its active ingredient, repaglinide, works by stimulating insulin release from pancreatic beta cells in response to elevated blood glucose. By enhancing insulin secretion only when glucose levels rise, the drug helps lower postprandial hyperglycemia in patients with type 2 diabetes. This glucose-dependent mechanism reduces the risk of hypoglycemia compared with some other oral agents. The medication is rapidly absorbed after ingestion and reaches peak concentration within an hour, allowing it to act on the immediate rise in glucose after meals. It inhibits the atp-dependent potassium channels on beta cells, leading to depolarization, calcium influx, and subsequent insulin granule exocytosis. The resulting increase in circulating insulin promotes cellular glucose uptake and storage, thereby normalizing blood glucose concentrations.

Prandin is a brand name for the oral antidiabetic drug repaglinide. It belongs to the class of meglitinides that stimulate insulin release from pancreatic beta cells. The medication lowers blood glucose by enhancing rapid insulin secretion after meals. It acts by binding to the sulfonylurea receptor on beta cells which leads to increased calcium influx. This interaction triggers discharge of pre-stored insulin from secretory vesicles. The effect is limited to the postprandial period and does not affect basal glucose production. Pharmacokinetics are characterized by quick absorption rapid peak activity and short duration of action.

The most common side effects of many medications include nausea, headache, and mild fatigue. Some people report temporary dizziness or light-headedness after dosing. Digestive discomfort such as stomach upset or diarrhea may occur. Skin reactions like redness or itching can appear in a small number of cases. Sleep disturbances, including difficulty falling asleep or restless nights, are reported. Mild flushing or warmth in the face may be experienced transiently. These effects often lessen over time as the body adjusts to the treatment.

Many medications can cause mild headache or dizziness in users. Some people experience temporary nausea or stomach discomfort after taking a dose. Fatigue is a frequent complaint, especially when treatment begins. Changes in appetite, such as increased or decreased hunger, may occur. Mild skin reactions, like redness or itching, are also reported. Occasional mild fever can appear as part of the body's response. Most of these effects are short lived and do not require medical attention.